|
1
|
Yung KW, Yung TT, Chung CY, Tong GT, Liu
Y, Henderson J, Welbeck D and Oseni S: Principles of cancer
staging. Asian Pac J Surg Oncol. 1:1–16. 2015.
|
|
2
|
Guo F, Guo L, Li Y, Zhou Q and Li Z:
MALAT1 is an oncogenic long non-coding RNA associated with tumor
invasion in non-small cell lung cancer regulated by DNA
methylation. Int J Clin Exp Pathol. 8:15903–15910. 2015.PubMed/NCBI
|
|
3
|
Liu Y, Tan J, Li L, Li S, Zou S, Zhang Y,
Zhang X, Ling B, Han N, Guo S, et al: Study on the molecular
mechanisms of dlk1 stimulated lung cancer cell proliferation.
Zhongguo Fei Ai Za Zhi. 13:923–927. 2010.(In Chinese). PubMed/NCBI
|
|
4
|
Yue LZ, Fu R, Wang HQ, Li LJ, Ruan EB,
Wang GJ, Qu W, Liang Y, Guan J, Wu YH, et al: Expression of DLK1
gene in the bone marrow cells of patients with myelodysplastic
syndromes and its clinical significance. Cancer Biol Med.
9:188–191. 2012.PubMed/NCBI
|
|
5
|
Sakajiri S, O'kelly J, Yin D, Miller CW,
Hofmann WK, Oshimi K, Shih LY, Kim KH, Sul HS, Jensen CH, et al:
Dlk1 in normal and abnormal hematopoiesis. Leukemia. 19:1404–1410.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nueda ML, Baladrón V, Sánchez-Solana B,
Ballesteros MA and Laborda J: The EGF-like protein dlk1 inhibits
notch signaling and potentiates adipogenesis of mesenchymal cells.
J Mol Biol. 367:1281–1293. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li L, Tan J, Zhang Y, Han N, Di X, Xiao T,
Cheng S, Gao Y and Liu Y: DLK1 promotes lung cancer cell invasion
through upregulation of MMP9 expression depending on Notch
signaling. PLoS One. 9:e915092014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tabouret E, Bertucci F, Pierga JY, Petit
T, Levy C, Ferrero JM, Campone M, Gligorov J, Lerebours F, Roché H,
et al: MMP2 and MMP9 serum levels are associated with favorable
outcome in patients with inflammatory breast cancer treated with
bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.
Oncotarget. 23:15–16. 2016.
|
|
9
|
Moz S, Basso D, Padoan A, Bozzato D, Fogar
P, Zambon CF, Pelloso M, Sperti C, de Kreutzenberg S Vigili,
Pasquali C, et al: Blood expression of matrix metalloproteinases 8
and 9 and of their inducers S100A8 and S100A9 supports diagnosis
and prognosis of PDAC-associated diabetes mellitus. Clin Chim Acta.
456:24–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pogribny IP and Beland FA: DNA
hypomethylation in the origin and pathogenesis of human diseases.
Cell Mol Life Sci. 66:2249–2261. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Esteller M and Herman JG: Cancer as an
epigenetic disease: DNA methylation and chromatin alterations in
human tumours. J Pathol. 196:1–7. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suter CM, Martin DI and Ward RL: Germline
epimutation of MLH1 in individuals with multiple cancers. Nat
Genet. 36:497–501. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cui H, Onyango P, Brandenburg S, Wu Y,
Hsieh CL and Feinberg AP: Loss of imprinting in colorectal cancer
linked to hypomethylation of H19 and IGF2. Cancer Res.
62:6442–6446. 2002.PubMed/NCBI
|
|
15
|
Kanai Y: Genome-wide DNA methylation
profiles in precancerous conditions and cancers. Cancer Sci.
101:36–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Belinsky SA: Gene-promoter
hypermethylation as a biomarker in lung cancer. Nat Rev Cancer.
4:707–717. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Caceres I Ibanez, Cortes-Sempere M,
Moratilla C, Machado-Pinilla R, Rodriguez-Fanjul V, Manguán-García
C, Cejas P, López-Ríos F, Paz-Ares L, de CastroCarpeño J, et al:
IGFBP-3 hypermethylation-derived deficiency mediates cisplatin
resistance in non-small-cell lung cancer. Oncogene. 29:1681–1690.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang X, Lay F, Han H and Jones PA:
Targeting DNA methylation for epigenetic therapy. Trends Pharmacol
Sci. 31:536–546. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA. 93:pp.
9821–9826. 1996; View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wani K and Aldape KD: PCR techniques in
characterizing DNA methylation. Methods Mol Biol. 1392:177–186.
2016. View Article : Google Scholar : PubMed/NCBI
|
